Jane Street’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-61,900
Closed -$576K – 12003
2026
Q1
$576K Buy
+61,900
New +$539K ﹤0.01% 7716
2024
Q4
– Sell
-59,000
Closed -$638K – 9732
2024
Q3
$638K Buy
59,000
+19,400
+49% +$322K ﹤0.01% 6759
2024
Q2
$831K Sell
39,600
-900
-2% -$22.6K ﹤0.01% 6126
2024
Q1
$1.29M Buy
+40,500
New +$1.03M ﹤0.01% 4933

Other funds holding FDMT

Jane Street's FDMT Position: Q3 2026 in Review

Jane Street opened a new position in 4D Molecular Therapeutics (FDMT) in Q3 2026: 171,009 shares worth $2.45M. The stake represents ﹤0.01% of the portfolio and ranks #4807 among its holdings. This is a return to the name: Jane Street previously reported a position in FDMT as recently as Q1 2026.

Jane Street first reported a position in FDMT in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.8M in Q2 2024. 167 funds tracked by Wall St. Rank hold FDMT as of Q3 2026.

  • Jane Street held 171,009 shares of 4D Molecular Therapeutics worth $2.45M as of Q3 2026.
  • 4D Molecular Therapeutics was a new Jane Street position in Q3 2026.
  • 4D Molecular Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #4807 holding.
  • Jane Street first reported a position in 4D Molecular Therapeutics in Q4 2022 and has held it in 14 quarters since.
  • Jane Street's 4D Molecular Therapeutics position peaked at $2.8M in Q2 2024.
  • 167 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.